A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder

Journal of Autism and Developmental Disorders

Volumn 39, Issue 5, 2009, Pages 796-805

  Handen, Benjamin L ^a   Melmed, Raun D ^b   Hansen, Robin L ^c   Aman, Michael G ^d   Burnham, David L ^e,g   Bruss, Jon B ^e,h   McDougle, Christopher J ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Southwest Autism Research and Resource Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e PediaMed Pharmaceuticals   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g PRA International   (United States)

^h Alarus Developmental International   (United States)

Author keywords

Autism; Gastrointestinal symptoms; Oral human immunoglobulin

Indexed keywords

HUMAN IMMUNOGLOBULIN; ORALGAM; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AUTISM; BLOOD DISEASE; BRONCHITIS; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; EAR DISEASE; EVENING DOSAGE; EYE DISEASE; FEMALE; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INJURY; INNER EAR DISEASE; INTESTINE MOTILITY; IRRITABLE COLON; KIDNEY DISEASE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MORNING DOSAGE; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SIDE EFFECT; SKIN DISEASE; SUBCUTANEOUS TISSUE; THORAX DISEASE; VALIDATION PROCESS; VASCULAR DISEASE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CONSTIPATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULINS; IRRITABLE BOWEL SYNDROME; MALE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 67349270550     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-008-0687-y     Document Type: Article

References (40)

1. MG Aman 2005 Treatment planning for patients with autism spectrum disorders The Journal of Clinical Psychiatry 66 Suppl. 10 38 45
2. Aman, M. G., & Pearson, D. A. (1999). Monitoring and measuring drug effects. II. Behavioral, emotional, and cognitive effects (Vol. 2, pp. 99-164). New York, NY: Plenum Press.
3. MG Aman NN Singh AW Stewart CJ Field 1985 The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects American Journal of Mental Deficiency 89 485 491
4. MG Aman NN Singh AW Stewart CJ Field 1985 Psychometric characteristics of the aberrant behavior checklist American Journal of Mental Deficiency 89 492 502
5. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th ed. text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
6. LE Arnold MG Aman A Martin A Collier-Crespin B Vitiello E Tierney 2000 Assessment in multisite randomized clinical trials of patients with autistic disorder: The Autism RUPP Network. Research units on pediatric psychopharmacology Journal of Autism and Developmental Disorders 30 99 111 10.1023/A:1005451304303
7. P Ashwood A Anthony AA Pellicer F Torrente JA Walker-Smith AJ Wakefield 2003 Intestinal lymphocyte populations in children with regressive autism: Evidence for extensive mucosal immunopathology Journal of Clinical Immunology 23 504 517 10.1023/B:JOCI.0000010427.05143.bb
8. GL Barnes LW Doyle PH Hewson AM Knoches JA McLellan WH Kitchen 1982 A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus Lancet 1 1371 1373 10.1016/S0140-6736(82)92496-5
9. AK Bogstedt CE Nord L Hammarstrom 1995 Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora European Journal of Clinical Microbiology & Infectious Diseases 14 61 64 10.1007/BF02112623
10. SM Borowitz FT Saulsbury 1991 Treatment of chronic cryptosporidial infection with orally administered human serum immune globulin The Journal of Pediatrics 119 593 595 10.1016/S0022-3476(05)82412-6
11. GW Christison K Ivany 2006 Elimination diets in autism spectrum disorders: Any wheat amidst the chaff? Journal of Developmental and Behavioral Pediatrics 27 S162 S171 10.1097/00004703-200604002-00015
12. CA Erickson KA Stigler MR Crokins DJ Posey JF Fitzgerald CJ McDougle 2005 Gastrointestinal factors in autistic disorder: A critical review Journal of Autism and Developmental Disorders 35 713 727 10.1007/s10803-005-0019-4
13. S Folstein M Rutter 1997 Infantile autism: A genetic study of 21 twin pairs Journal of Child Psychology and Psychiatry, and Allied Disciplines 18 297 321 10.1111/j.1469-7610.1977.tb00443.x
14. RI Furlano A Anthony R Day A Brown L McGarvey MA Thomson 2001 Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism The Journal of Pediatrics 138 366 372 10.1067/mpd.2001.111323
15. S Gordon V Ameen B Bagby B Shahan P Jhingran E Carter 2003 Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy Digestive Diseases and Sciences 48 1317 1323 10.1023/A:1024159226274
16. A Guarino RB Canani S Russo F Albano MB Canani FM Ruggeri 1994 Oral immunoglobulins for treatment of acute rotaviral gastroenteritis Pediatrics 93 12 16
17. Guy, W. (1976a). ECDEU Assessment manual of psychopharmacology. Rockville, Md: National Institute of Mental Health USA Department of Health, Education, and Welfare publication (ADM), Psychopharmacology Research Branch, pp. 76-338.
18. Guy, W. (1976b). Dosage record and treatment emergent symptoms scale, ECDEU assessment manual for psychopharmacology (Revised). USA Department of Health, Education and Human Welfare publication (ADM), (pp. 223-244).
19. K Horvath JA Perman 2002 Autism and gastrointestinal symptoms Current Gastroenterology Reports 4 251 258 10.1007/s11894-002-0071-6
20. K Horvath JC Papadimitriou A Rabsztyn C Drachenberg JT Tildon 1999 Gastrointestinal abnormalities in children with autistic disorder The Journal of Pediatrics 135 559 563 10.1016/S0022-3476(99)70052-1
21. T Kuddo KB Nelson 2003 How common are gastrointestinal disorders in children with autism? Current Opinion in Pediatrics 15 339 343 10.1097/00008480-200306000-00020
22. SE Levy SL Hyman 2003 Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing Pediatric Annals 32 685 691
23. LA Linday JA Tsiouris IL Cohen R Shindledecker R DeCresce 2001 Famotidine treatment of children with autistic spectrum disorders: Pilot research using single subject research design Journal of Neural Transmission 108 593 611 10.1007/s007020170059
24. C Lord M Rutter A Le Couteur 1994 Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders Journal of Autism and Developmental Disorders 24 659 685 10.1007/BF02172145
25. GA Losonsky JP Johnson JA Winkelstein RH Yolken 1985 Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis The Journal of Clinical Investigation 76 2362 2367 10.1172/JCI112248
26. CA Molloy P Manning-Courtney 2003 Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders Autism 7 165 171 10.1177/1362361303007002004
27. DJ Posey MG Aman JT McCracken L Scahill E Tierney LE Arnold B Vitiello SZ Chuang M Davies Y Ramadan AN Witwer NB Swiezy P Cronin B Shah DH Carroll C Young C Wheeler CJ McDougle 2007 Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: An analysis of secondary measures Biological Psychiatry 61 538 544 10.1016/j.biopsych.2006. 09.028
28. Research Units on Pediatric Psychopharmacology Autism Network 2002 Risperidone in children with autism and serious behavioral problems The New England Journal of Medicine 347 314 321 10.1056/NEJMoa013171
29. RH Sandler SM Finegold E Bolte CP Buchanan AP Maxwell M Väisänen MN Nelson HM Wexler 2000 Short-term benefit from oral vancomycin treatment of regressive-onset Autism Journal of Child Neurology 15 429 435 10.1177/088307380001500701
30. CK Schneider RD Medmed FJ Enriquez LE Barstow J Ranger-Moore JA Ostrem 2006 Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study Journal of Autism and Developmental Disorders 36 1053 1064 10.1007/s10803-006-0141-y
31. VK Singh SX Lin VC Yang 1998 Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism Clinical Immunology and Immunopathology 89 105 108 10.1006/clin.1998.4588
32. TL Sweeten DJ Posey CJ McDougle 2004 Autistic disorder in three children with cytomegalovirus infection Journal of Autism and Developmental Disorders 34 583 586 10.1007/s10803-004-2552-y
33. CO Tacket G Losonsky H Link Y Hoang P Guesry H Hilpert 1988 Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli The New England Journal of Medicine 318 1240 1243
34. CO Tacket SB Binion E Bostwick G Losonsky MJ Roy R Edelman 1992 Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge The American Journal of Tropical Medicine and Hygiene 47 276 283
35. B Taylor E Miller R Lingam N Andrews A Simmons J Stowe 2002 Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study British Medical Journal 324 393 396 10.1136/bmj.324.7334.393
36. B Tjellstrom L Stenhammar S Eriksson KE Magnusson 1993 Oral immunoglobulin a supplement in treatment of Clostridium difficile enteritis Lancet 341 701 702 10.1016/0140-6736(93)90477-X
37. B Tjellstrom L Stenhammar KE Magnusson T Sandqvist 1997 Oral immunoglobulin treatment in Crohn's disease Acta Paediatrica 86 221 223 10.1111/j.1651-2227.1997.tb08873.x (Oslo, Norway)
38. F Torrente P Ashwood R Day N Machado RI Furlano A Anthony 2002 Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism Molecular Psychiatry 7 375 382
39. M Valicenti-McDermott K McVicar I Rapin BK Wershil H Cohen S Shinnar 2006 Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease Journal of Developmental and Behavioral Pediatrics 27 S128 S136 10.1097/00004703-200604002- 00011
40. T van Gent CJ Heijnen PD Treffers 1997 Autism and the immune system Journal of Child Psychology and Psychiatry, and Allied Disciplines 38 337 349 10.1111/j.1469-7610.1997.tb01518.x